UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000635
Receipt number R000000769
Scientific Title Efficacy of lutein supplement on macular pigments density and visual performance of age-related macular degeneration (AMD) patients
Date of disclosure of the study information 2007/03/11
Last modified on 2009/09/11 16:14:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of lutein supplement on macular pigments density and visual performance of age-related macular degeneration (AMD) patients

Acronym

Efficacy of lutein supplement on age-related macular degeneration

Scientific Title

Efficacy of lutein supplement on macular pigments density and visual performance of age-related macular degeneration (AMD) patients

Scientific Title:Acronym

Efficacy of lutein supplement on age-related macular degeneration

Region

Japan


Condition

Condition

age-related macular degeneration (AMD) patients

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will measure the macular pigment density and the change of visual functions after administration of lutein supplements on age-related macular degeneration patients, and evaluate the therapeutic effects of lutein for age-related macular degeneration.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Measurements of visual acuity, contrast sensitivity, metamorphopsia graded by M-chart, perimetric mean sensitivity, and macular pigment density

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

One capsule containing 10 mg of lutein and 0.8 mg of zeaxanthin is administered to each participants once a day for 12 months

Interventions/Control_2

One capsule of placebo supplement is administered to each participants once a day for 12 months

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Patients having either early age-related maculopathy (ARM), exudative age-related macular degeneration (AMD), or atrophic AMD
(2) Patients showing either visual acuity of less than 1.0, decreased contrast sensitivity, metamorphopsia detected by M-cahrt, or decreased perimetric mean sensitivity measured by Humphry visual field analyzer (program 10-2)
(3) Patients aged 50-year-old or more and can sign an informed consent form for participation of this study
(4) Patients whom the principal investigator judges competent
(5) Patients with no lutein allergy

Key exclusion criteria

(1) Eyes with cataract that affect the measurement of visual function tests.
(2) Eyes received cataract surgery within six months
(3) Eyes with glaucoma, diabetic retinopathy and any other eye disease
(4) Patient with serious disease in liver, kidney or heart that impacts on the evaluation of the use of lutein supplements
(5) Patient who is taking photosensitive medicine, such as phenothiazine, chloroquine or tetracycline
(6) Patient who involved in the other clinical trials within three months
(7) Others. Patients whom the principal investigator judges incompetent

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akira Obana, MD, PhD

Organization

Seirei Hamamatsu General Hospital

Division name

Department of Ophthalmology

Zip code


Address

2-12-12 Sumiyoshi, Hamamatsu, Shizuoka, 430-8558, Japan

TEL

053-430-2222

Email



Public contact

Name of contact person

1st name
Middle name
Last name Akira Obana, MD, PhD

Organization

Seirei Hamamatsu General Hospital

Division name

Department of Ophthalmology

Zip code


Address

2-12-12 Sumiyoshi, Hamamatsu, Shizuoka, 430-8558, Japan

TEL

053-430-2222

Homepage URL


Email

obana@sis.seirei.or.jp


Sponsor or person

Institute

Raman Study Team

Institute

Department

Personal name



Funding Source

Organization

Seirei Hamamatsu General Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

None

Name of secondary funder(s)

Kemin Japan, Koyo Mercantile Co., LTD


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 03 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2006 Year 12 Month 11 Day

Date of IRB


Anticipated trial start date

2007 Year 03 Month 01 Day

Last follow-up date

2009 Year 03 Month 01 Day

Date of closure to data entry

2009 Year 09 Month 01 Day

Date trial data considered complete

2009 Year 09 Month 01 Day

Date analysis concluded

2010 Year 07 Month 01 Day


Other

Other related information



Management information

Registered date

2007 Year 03 Month 11 Day

Last modified on

2009 Year 09 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000769


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name